Congress Asset Management CO Global Blood Therapeutics, Inc. Transaction History

Congress Asset Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 25, 2019	SELL	$31.54 - $46.67 $827,104 - $1.22 Million	-26,224 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$38.0 - $51.1 $424,194 - $570,429	-11,163 Reduced 29.86%	26,224 $997,000
Q1 2018 May 11, 2018	BUY	$39.6 - $65.9 $10,256 - $17,068	259 Added 0.7%	37,387 $1.81 Million
Q4 2017 Jan 30, 2018	SELL	$29.7 - $45.7 $518,116 - $797,236	-17,445 Reduced 31.97%	37,128 $1.46 Million
Q3 2017 Oct 17, 2017	BUY	$25.1 - $31.05 $1.37 Million - $1.69 Million	54,573	54,573 $1.69 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

Stay updated on Congress Asset Management CO with notifications on news.